AMBROSIA VENTURES LLP
Ambrosia Ventures LLP is a boutique life sciences consulting and M&A advisory firm serving biotech, pharma, medtech companies, and investors with strategic consulting, deal execution, and investor readiness services supported by its proprietary alaric analytics platform.
- Company typePrivate
- Founded2023
- HeadquartersDetroit, United States
- Headcount1–10
- GTM typeB2B
- OfferingServices
What AMBROSIA VENTURES LLP does
Ambrosia Ventures LLP is a boutique strategic consulting and M&A advisory firm focused on the life sciences sector. Founded in 2023 by Issa Kildani as Founder & Managing Partner, the firm serves biotech, pharmaceutical, and medtech companies alongside investors, private equity firms, and corporate leadership teams. Service lines are organized around three pillars: Strategic Consulting (market intelligence, corporate strategy, go-to-market, organizational transformation), M&A Advisory and Deal Execution (target identification, commercial/scientific due diligence, valuation, deal structuring, and post-merger integration), and Investor and Licensing Strategy (fundraising readiness, in/out-licensing, and regulatory compliance advisory). The firm claims a global operating footprint spanning the US, UK, India, China, Singapore, and Brazil.
The firm's technology layer centers on alaric, a proprietary Life Sciences M&A Analytics Tool launched in 2025 that provides benchmarking, market forecasting, and M&A intelligence. Adjacent capabilities include AI-driven data hubs for real-time market and customer analytics, and blockchain consulting for biotech supply chain traceability and clinical trial data integrity. The firm references predictive analytics, NLP-based contract analysis (using named third-party tools such as Kira and Seal), generative AI, and machine learning for applications ranging from market forecasting to genomic target identification and virtual screening. These AI capabilities are positioned as supplementary to human-led advisory delivery rather than as standalone products.
The business model is professional services-based: engagements are sold direct via the firm website and Calendly-scheduled strategy calls, with quote-based pricing that can be structured as flat fees, time and materials, or success-based arrangements. Go-to-market is sales-led, supported by content marketing through a blog, active social presence on LinkedIn, Facebook, and Instagram, and participation in industry conferences. The firm is privately held with no disclosed institutional investment, no parent company, and no reported revenue or headcount.
AMBROSIA VENTURES LLP firmographics
Firmographics- Name
- AMBROSIA VENTURES LLP
- Legal name
- Ambrosia Ventures LLP
- Website
- https://ambrosiaventures.co
- Company type
- Private
- Founded year
- 2023
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Ambrosia Ventures LLP is a boutique life sciences consulting and M&A advisory firm serving biotech, pharma, medtech companies, and investors with strategic consulting, deal execution, and investor readiness services supported by its proprietary alaric analytics platform.
- Ownership category
- akta.pro rank
AMBROSIA VENTURES LLP industry classification
Industry- Product category
- Life Sciences Management Consulting
- NAICS
- Management Consulting Services (54161), Securities, Commodity Contracts, and Other Financial Investments and Related Activities (523), Miscellaneous Intermediation (52391), Other Management Consulting Services (541618)
- SIC
- Services-Management Consulting Services (8742), Services-Engineering, Accounting, Research, Management (8700)
- akta.pro primary industry
- Industry-Specialist / Sector-Focused M&A Advisory (FSAEAGAJ)
- akta.pro secondary industries
- M&A Advisory (Buy-Side & Sell-Side) (BPAHAOAA), Strategy & Corporate Development Consulting (BPAHACAA), Buy-Side M&A Advisory (FSAEAGAB), Corporate Development & Strategic Partnerships Advisory (JVs, Alliances, Carve-outs) (BPAHAOAG)
Keywords
Where AMBROSIA VENTURES LLP is headquartered
LocationHeadquarters
- HQ city
- Detroit
- HQ country
- United States
- HQ region
- North America
Markets served
AMBROSIA VENTURES LLP business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Others
Revenue model
- Strategic Consulting Services: Advisory engagements providing life sciences business consulting including market intelligence, corporate strategy, organizational transformation, and go-to-market strategies. Delivered as customized advisory projects tailored to each client's unique objectives.
- M&A Advisory Services: Deal execution support including target identification, due diligence, valuation, deal structuring, negotiation, and post-merger integration services for life sciences transactions.
- Investor & Licensing Advisory: Investor readiness, fundraising support, in-licensing and out-licensing facilitation, and regulatory compliance advisory for life sciences companies and investors.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Custom consulting engagements with quote-based pricing |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels5 records
AMBROSIA VENTURES LLP product offering
Product offeringCore offering
Ambrosia Ventures is a boutique consulting firm that delivers strategic consulting, M&A advisory, and investor/licensing advisory services to life sciences companies. Its core deliverables include market intelligence, corporate and go-to-market strategy, target identification, due diligence, deal structuring, post-merger integration, and fundraising support for biotech, pharma, and medtech clients. Engagements are delivered by senior advisors and underpinned by a proprietary Life Sciences M&A Analytics Tool (alaric) and AI-driven analytics.
Product overview
Ambrosia Ventures LLP is a boutique strategic consulting and M&A advisory firm specializing in the life sciences sector. The firm operates as a services-based consultancy rather than a software platform, offering strategic consulting, M&A advisory, and investor/ licensing strategy as its core service lines. The Life Sciences M&A Analytics Tool (alaric) serves as a proprietary analytics platform that underpins the firm's consulting engagements, providing benchmarking, forecasting, and intelligence capabilities. AI-driven data hubs and biotech blockchain solutions represent technology capabilities the firm employs to deliver insights on market performance, clinical trial optimization, and supply chain transparency. The core offering is human-led consulting supplemented by proprietary analytical tools and AI-enabled data processing.
Differentiator
Problem solved
Functional benefit
Products and services
- Strategic Consulting Services Life sciences business consulting covering market intelligence and competitive positioning, corporate strategy and organizational transformation, and go-to-market and commercialization strategy for biotech, pharma, and medtech companies. Includes AI-driven operational excellence for R&D, clinical trials, and manufacturing optimization.
- M&A Advisory & Deal Execution M&A advisory covering target identification and market mapping, commercial and scientific due diligence and valuation, deal structuring and negotiation, and post-merger integration strategy for life sciences transactions.
- Investor & Licensing Strategy Investor readiness and fundraising support for IPOs and private equity funding, in-licensing and out-licensing facilitation for drug assets and IP, and regulatory risk and compliance advisory for life sciences companies and investors.
- Life Sciences M&A Analytics Tool (alaric) Proprietary analytics platform providing high-precision benchmarking, market forecasting, M&A intelligence, and strategic insights for biotech and pharmaceutical clients across deal identification, valuation, and post-merger integration phases.
Quantifiable outcome
- Proven track record measured by clients' continued growth and successful deal closures
Companies that use AMBROSIA VENTURES LLP
Customer profileSegments4 records
Ideal customer profiles4 records
AMBROSIA VENTURES LLP technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability11 records
Feature3 records
AMBROSIA VENTURES LLP partnerships and signals
Strategic signalScale indicators1 record
Recent moves1 record
Expansion highlights4 records
AMBROSIA VENTURES LLP competitors and assessment
Company assessmentDirect peers
- Health Advances: Specialized strategy consulting firm for life sciences companies and investors, providing commercial diligence, M&A advisory, and strategic assessments — a near-direct competitor to Ambrosia in size and life sciences M&A focus.
- Back Bay Life Science Advisors: Boutique life sciences-focused advisory firm providing commercial diligence, strategic advisory, and financing support to biotech and pharma companies and investors — directly comparable in size, specialization, and M&A advisory positioning.
- ClearView Healthcare Partners: Boutique life sciences strategy consulting firm focused on biotech, pharma, and medtech, offering commercial diligence, M&A support, and strategic advisory — a closest direct competitor to Ambrosia given similar size, vertical specialization, and service offering.
- Trinity Partners: Life sciences-focused strategy consulting firm offering commercial strategy, market research, and transaction advisory to biotech and pharma — a comparable boutique competitor with similar vertical focus and client base.
- Putnam Associates: Life sciences-focused strategy consulting firm serving biotech and pharma on commercial strategy, market access, and transaction support — directly comparable boutique competitor with similar vertical specialization and engagement types.
Broad incumbents
- Simon-Kucher & Partners: Global consulting firm with a substantial life sciences practice covering commercial strategy, pricing, and M&A support for pharma and biotech — competes with Ambrosia on strategy and licensing/commercialization engagements.
- L.E.K. Consulting: Global strategy consulting firm with one of the largest dedicated life sciences practices, providing strategy, M&A advisory, and commercial diligence to biotech and pharma — directly comparable in service mix but at vastly larger scale and brand recognition than Ambrosia Ventures.
- ZS Associates: Global consulting firm with a deep life sciences practice combining strategy consulting, M&A advisory, and analytics/AI capabilities for pharma and biotech — overlaps with Ambrosia's services and AI/analytics positioning but at materially larger scale.
- Charles River Associates: Global consulting firm with a Life Sciences practice providing M&A advisory, commercial diligence, and strategy consulting for biotech and pharma — overlaps broadly with Ambrosia's M&A and strategic consulting service lines.
- Alvarez & Marsal Life Sciences: Global professional services firm with a dedicated Life Sciences practice providing transaction advisory, restructuring, and operational consulting to biotech and pharma — a comparable services competitor in life sciences M&A and turnaround advisory.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
AMBROSIA VENTURES LLP social profiles
Digital presenceAMBROSIA VENTURES LLP financial estimates
Financial estimateRevenue estimate
Valuation estimate
AMBROSIA VENTURES LLP leadership team
Management profileNumber of profiles
Profiles1 record
AMBROSIA VENTURES LLP funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
AMBROSIA VENTURES LLP M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about AMBROSIA VENTURES LLP
What does AMBROSIA VENTURES LLP do?
Ambrosia Ventures is a boutique consulting firm that delivers strategic consulting, M&A advisory, and investor/licensing advisory services to life sciences companies. Its core deliverables include market intelligence, corporate and go-to-market strategy, target identification, due diligence, deal structuring, post-merger integration, and fundraising support for biotech, pharma, and medtech clients. Engagements are delivered by senior advisors and underpinned by a proprietary Life Sciences M&A Analytics Tool (alaric) and AI-driven analytics.
Is AMBROSIA VENTURES LLP a public or private company?
AMBROSIA VENTURES LLP is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was AMBROSIA VENTURES LLP founded?
AMBROSIA VENTURES LLP was founded in 2023. It employs 1 to 10 people.
Where is AMBROSIA VENTURES LLP based?
AMBROSIA VENTURES LLP is headquartered in Detroit, United States, in the North America region.
How does AMBROSIA VENTURES LLP make money?
Three revenue lines are on record. Strategic Consulting Services are the primary driver. The others are M&A Advisory Services and investor & Licensing Advisory.
Who are AMBROSIA VENTURES LLP's main competitors?
Direct peers on record are Health Advances, Back Bay Life Science Advisors, ClearView Healthcare Partners, Trinity Partners and Putnam Associates. Broad incumbents are Simon-Kucher & Partners, L.E.K. Consulting, ZS Associates, Charles River Associates and Alvarez & Marsal Life Sciences.
Does AMBROSIA VENTURES LLP have an API?
No public API is recorded for AMBROSIA VENTURES LLP.
What industry is AMBROSIA VENTURES LLP in?
AMBROSIA VENTURES LLP's product category is Life Sciences Management Consulting. Its primary akta.pro industry code is FSAEAGAJ, Industry-Specialist / Sector-Focused M&A Advisory, with a secondary code of BPAHAOAA, M&A Advisory (Buy-Side & Sell-Side). Its NAICS code is 54161 and its SIC code is 8742.